Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources

Abstract excerpt

Clinical implementation of pharmacogenomics (PGx) is slow. Previous studies have identified some inconsistencies among clinical PGx recommendations, but the prevalence and types of inconsistencies have not been comprehensively analyzed among major PGx guidance sources in the U.S. PGx recommendations from the Clinical Pharmacogenetics Implementation Consortium, U.S. Food and Drug Administration drug labels, and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Health Systems, Economic Evaluations, Quality of Life
• Share to Pharmaceutical studies and practices
• Share to Pharmacogenetics and Drug Metabolism